W Jacot

Discipline

Economies et finances (1) Anthropologie biologique (1)

Type de document

Articles (4)

Co-auteur

Date

Source

Mot-clé

Cancer (3) Breast (3) tumeur (2) analyse (2) adulte (2) cancer (2) Cancer (2) Methods (2) Epidermal growth factor (2) Patients (2) Human beings (2) Older people (2) Methods (2) Analysis (2) Patients (2) adulte (2) puits (1) biologie (1) toxicité (1) temps (durée) (1) thérapie (1) sécurité (1) mutation (1) fusion (1) immunité (1) évaluation (1) dose (1) ADN (1) investigation (1) âge (1)

Documents écrit par W Jacot (4) | parle de W Jacot (0)

Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.
Dell'Ova M. et al. (2015)
Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles.
W. Jacot et al. (2011)
Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.
P.J. Lamy et al. (2011)
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice.
M.Z. Ladjemi et al. (2011)